Epizyme, Inc.
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS

Last updated:

Abstract:

The present invention relates to substituted purine and 7-deazapurine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Status:
Application
Type:

Utility

Filling date:

10 Jun 2020

Issue date:

19 Aug 2021